Glenmede Trust CO Na Viatris Inc Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Viatris Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 22,349 shares of VTRS stock, worth $282,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,349
Previous 20,555
8.73%
Holding current value
$282,044
Previous $218,000
18.81%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
930MCall Options Held
2.68MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA141MShares$1.78 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$797 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$791 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$616 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...